Literature DB >> 14558178

Approaches to combat with confounding by indication in observational studies of intended drug effects.

Alex D McMahon1.   

Abstract

There has been a resurgence of controversy about the usefulness of observational data to study the efficacy of drugs. Nearly every week a researcher makes some criticism of clinical trials or justifies observational research into intended effects, with other researchers offering a contradictory viewpoint. Literature reviews are not useful in this regard because the contradictory studies will not usually be carried out. Some methods are discussed which may have potential utility in the study of intended effects. There may be a marginal role for statistical techniques such as propensity scores and confounder scores. More promising techniques may include ecological analyses, restriction of subjects and blinded prospective review. Because it is currently unknown when the observational study of drug efficacy is possible, we should arguably always carry out a study of the determinants of prescribing first, and possibly consider using the various techniques that are outlined in this article.

Mesh:

Year:  2003        PMID: 14558178     DOI: 10.1002/pds.883

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  37 in total

Review 1.  Interpretation of observational studies.

Authors:  P Jepsen; S P Johnsen; M W Gillman; H T Sørensen
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

2.  Prognostic studies of perioperative risk: robust methodology is needed.

Authors:  M P W Grocott; R M Pearse
Journal:  Br J Anaesth       Date:  2010-09       Impact factor: 9.166

3.  Confounding by drug formulary restriction in pharmacoepidemiologic research.

Authors:  Kristian B Filion; Maria Eberg; Pierre Ernst
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-12-09       Impact factor: 2.890

4.  A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin.

Authors:  David N Juurlink; Muhammad M Mamdani; Alexander Kopp; Nathan Herrmann; Andreas Laupacis
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

5.  Understanding adherence to official guidelines on statin prescribing in primary health care--a multi-level methodological approach.

Authors:  H Ohlsson; U Lindblad; T Lithman; B Ericsson; U-G Gerdtham; A Melander; L Råstam; J Merlo
Journal:  Eur J Clin Pharmacol       Date:  2005-10-19       Impact factor: 2.953

6.  Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2005-06-11

7.  Use of the dose, time, susceptibility (DoTS) classification scheme for adverse drug reactions in pharmacovigilance planning.

Authors:  Torbjörn Callréus
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

8.  Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable.

Authors:  M Alan Brookhart; Philip S Wang; Daniel H Solomon; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2006-05       Impact factor: 4.822

Review 9.  The contribution of observational studies to the knowledge of drug effectiveness in heart failure.

Authors:  Daniela Dobre; Dirk J van Veldhuisen; Mike J L DeJongste; Eric van Sonderen; Olaf H Klungel; Robbert Sanderman; Adelita V Ranchor; Flora M Haaijer-Ruskamp
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

10.  Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.

Authors:  Jeremy A Rassen; Robert J Glynn; M Alan Brookhart; Sebastian Schneeweiss
Journal:  Am J Epidemiol       Date:  2011-05-20       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.